MDCXW
Medicus Pharma Ltd. NASDAQ$0.55
Mkt Cap $12.0M
52w Low $0.40
6.9% of range
52w High $2.50
50d MA $2.50
200d MA $2.50
P/E (TTM)
-0.3x
EV/EBITDA
-1.2x
P/B
242.0x
Debt/Equity
-59.1x
ROE
69990.7%
P/FCF
-1.2x
RSI (14)
—
ATR (14)
—
Beta
-0.04
50d MA
$2.50
200d MA
$2.50
Avg Volume
3.7K
About
Medicus Pharma Ltd. is a clinical-stage biotech company focused on accelerating the development of novel therapeutic assets. Their lead subsidiary, SkinJect Inc., is developing a non-invasive treatment for basal cell carcinoma using a dissolvable microneedle patch to deliver chemotherapeutic agents directly to tumor cells.
Recent Earnings
| Date | Time | Est | Rptd | Surp | Base | Gap% | D1% | D2% | D3% | D4% | D5% | Guide ▲★ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Mar 26, 2026 | AMC | -0.07 | -0.63 | -800.0% | 0.68 | -14.6% | -17.6% | +39.8% | +0.0% | +0.0% | +0.0% | — |
| Nov 14, 2025 | AMC | -0.94 | -0.86 | +9.2% | 0.98 | -0.9% | -2.9% | +155.4% | +155.4% | +0.6% | +0.6% | — |
| Aug 12, 2025 | AMC | -0.25 | -0.43 | -73.0% | 2.50 | -71.2% | -74.0% | +0.0% | -74.0% | -72.8% | -68.4% | — |
| May 14, 2025 | AMC | -0.25 | -0.42 | -68.5% | 1.72 | +27.9% | -30.2% | +27.3% | +59.3% | +80.2% | +83.7% | — |
Data updated apr 28, 2026 2:39pm
· Source: massive.com